RiverPark Advisors »

Phathom Pharmaceuticals shares owned by RiverPark Advisors

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by RiverPark Advisors from 13F filings

Historical chart of RiverPark Advisors investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by RiverPark Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by RiverPark Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $47k 2.8k 16.59

More positions owned by RiverPark Advisors

Fubotv Note 3.250% 2/1 (Principal)
Dayforce Note 0.250% 3/1 (Principal)
Airbnb Note 3/1 (Principal)
Bentley Sys Note 0.125% 1/1 (Principal)
Dropbox Note 3/0 (Principal)
Confluent Note 1/1 (Principal)
Magnite Note 0.250% 3/1 (Principal)
Vail Resorts Note 1/0 (Principal)
Cantor Equity Partners Iii I Shs Cl A (CAEP)
Kochav Defense Acqui Shs Cl A (KCHV)
Live Oak Acquisition Corp V Cl A Shs (LOKV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Soulpower Acquisition Corp Usd Cl A Ord Shs (SOUL)
Inflection Pt Acquisition Cl A Ord Shs (IPCX)

View all positions for RiverPark Advisors

Top funds holding Phathom Pharmaceuticals

Frazier Life Sciences Management
Medicxi Ventures Management
Millennium Management
Invesco
BlackRock
Carlyle
Vanguard Group
Ensign Peak Advisors
NEA Management Company
683 Capital Management
Catalys Pacific
Daniel D. Thurber
Jennifer Ranahan
State Street Corporation
Geode Capital Management

View all funds holding Phathom Pharmaceuticals